Health
Experimental safety switch reduces severity of CAR-T immunotherapy-related side effects – News-Medical.Net
UNC Lineberger Comprehensive Cancer Center researchers have successfully used an experimental safety switch, incorporated as part of a chimeric antigen receptor…
UNC Lineberger Comprehensive Cancer Center researchers have successfully used an experimental safety switch, incorporated as part of a chimeric antigen receptor T-cell (CAR-T) therapy, a type of immunotherapy, to reduce the severity of treatment side effects that sometimes occur. This advance was seen in a patient enrolled in a clinical trial using CAR-T to treat refractory acute B-cell leukemia. It demonstrates a proof-of-principle for possible expanded use of CAR-T immunotherapy paired with the…
-
General17 hours agoMore buses without dedicated lanes likely after Gold Coast light rail plan scrapped
-
Business23 hours agoBuy this monthly high-yield ETF instead
-
Business21 hours agoThis artificial intelligence (AI) stock could be the Nvidia of quantum computing
-
Business21 hours agoTesla just offered Elon Musk $1 trillion. Here’s what it could mean for the company.